GLP-1 Providers That Prescribe Wegovy and Zepbound in 2026 (Verified Routes)

The bottom line, up front

The best GLP-1 providers that prescribe Wegovy and Zepbound depend on whether you need insurance help, cash-pay pricing, no subscription, or just a fill route for an existing prescription. After verifying every major U.S. GLP-1 telehealth platform on May 2, 2026, here’s how the routes break down:

• Best for most people with commercial insurance: Ro Body — free GLP-1 Insurance Coverage Checker, an insurance concierge that handles prior authorization paperwork, and one of the broadest publicly listed brand-name GLP-1 formularies (Wegovy pen, Wegovy pill, Zepbound pen, Zepbound KwikPen, plus Foundayo). Membership is $39 the first month, then $149/month — or as low as $74/month with annual prepay. Wegovy pill starts at $149/month and Wegovy pen at $199/month at intro pricing. Zepbound KwikPen runs up to $449/month at LillyDirect-matched prices.
• Best for cash-pay, no subscription: Walgreens Weight Management — $49 per visit, no membership, manufacturer-matched medication pricing. Available to eligible adults ages 18–64.
• Best for picking your own clinician: Sesame Care — $99/month (or $59/month on annual), same-day video visits, Wegovy and Zepbound listed.
• Other verified dual-brand routes: Hims & Hers (LillyDirect routing for Zepbound and Foundayo + Novo collaboration for Wegovy), WeightWatchers Clinic (commercial insurance only), Eden, Found, Noom Med, GoodRx Care, and Amazon Pharmacy via One Medical.
• If you already have a valid prescription, you may not need a telehealth platform at all. NovoCare Pharmacy (Wegovy direct), LillyDirect (Zepbound direct), Amazon Pharmacy, and your local pharmacy can fill it without a recurring care fee.

That’s the answer. The rest of this page tells you exactly why, what each route really costs, who handles your insurance, and the trap nobody warns you about: the provider’s care fee and the medication itself are billed separately. Most people don’t realize that until checkout.

Best Wegovy + Zepbound route, by your situation

Verified May 2, 2026. Re-check before signing up — manufacturer self-pay programs run on dated cycles.

See your real copay before paying anything. Free, no membership commitment, no payment to view your coverage report.

Which GLP-1 providers prescribe Wegovy and Zepbound online?

As of May 2, 2026, multiple legitimate U.S. telehealth services support both brand-name Wegovy (semaglutide, made by Novo Nordisk) and brand-name Zepbound (tirzepatide, made by Eli Lilly). The verified dual-brand routes are: Ro Body, Sesame Care, Walgreens Weight Management, WeightWatchers Clinic, Hims & Hers, Eden, Found, Noom Med, GoodRx Care, and Amazon Pharmacy via One Medical. Direct manufacturer programs (NovoCare Pharmacy, LillyDirect) sell single-brand only and require a prescription you already have.

This page exists because the obvious search — “where do I get Wegovy” — and the other obvious search — “where do I get Zepbound” — turn up different lists. If you’re flexible about which medication you take, you want a route whose clinician can actually pick between the two for you, or a pharmacy that can fill either prescription you already hold.

The verified provider matrix

Every cell was checked against the source’s live page on May 2, 2026. Sources are cited at the bottom of this page.

Decision Resolution Point: If you have commercial insurance, your single most useful next step is Ro’s free coverage checker. It tells you whether your plan covers Wegovy or Zepbound and at what copay — before you pay a dollar to anyone.

Run Ro’s free GLP-1 Insurance Coverage Checker (free; requires basic insurance info to generate the report; no membership commitment)

What providers claim vs. what we verified

The gap between what a brand says and what’s actually on their live page is where most “best of” lists fall apart. Here’s the verification log for the dual-brand routes.

We also confirmed which provider does not belong on this list:

• Direct manufacturer programs (NovoCare Pharmacy and LillyDirect) sell only their own company’s brand. NovoCare carries Wegovy and Ozempic only. LillyDirect carries Zepbound, Mounjaro, and Foundayo only. These are pharmacy fulfillment routes, not prescribers — you bring an existing prescription.

What you’ll really pay — provider fee vs. medication fee

Online GLP-1 care has two separate costs almost nobody compares correctly: the provider’s care fee (membership, visit, or program fee) and the medication itself. Self-pay medication prices in 2026 are set by Novo Nordisk and Eli Lilly and matched by most major telehealth platforms. As of May 2, 2026: Wegovy starts at $149/month for the pill and $199/month for the pen at intro pricing. Zepbound starts at $299/month for the lowest dose and runs up to $449/month for higher doses through LillyDirect’s Self-Pay Journey Program. The provider’s care fee adds on top of that.

Here’s the trap. Most “best Wegovy provider” pages quote you a price like “$199/month.” That’s the medication. They don’t tell you the provider also charges a recurring fee for writing the prescription, messaging, refills, and follow-up. Some don’t charge a recurring fee at all — they bill per visit. The provider’s care fee is where the experience differs. The medication price is mostly the same across legitimate providers, because they all match the manufacturer’s self-pay program.

Self-pay medication prices, verified May 2, 2026

1. Government beneficiaries are excluded from manufacturer self-pay savings. Medicare, Medicaid, VA, TRICARE, and any other government plan can’t use the Wegovy Savings Offer or the Zepbound Savings Card. Medicare patients can pay cash through LillyDirect — they just can’t use the discount programs.
2. The Zepbound 45-day rule is real. For doses 7.5 mg and higher, you must refill within 45 days of your previous delivery to keep the $449/month price. Miss it, and the price reverts to the standard tier ($499 for 7.5 mg, $699 for 10 / 12.5 / 15 mg). Set a reminder around day 30. You can re-enroll on your next order.
3. Insurance can be cheaper than cash. A $25 copay through commercial insurance beats every cash price on this list. The catch is that Wegovy and Zepbound usually require prior authorization — the work of getting your insurer to approve coverage. That’s why insurance support matters more than the membership fee for most people.

What each provider charges on top

First-90-day total cost — sample scenarios

Across the major dual-brand routes, the first 90 days of care plus medication run roughly $545–$1,234 for cash-pay patients on intro-priced Wegovy pill or low-dose Zepbound. With commercial insurance approval, the medication itself can drop to $25/month, making the membership fee the largest part of your total cost.

These numbers assume you’re paying cash, you’re starting on intro-priced doses, and you don’t yet know whether insurance will cover you.

The point: Walgreens and the manufacturer-direct route are cheapest if you don’t need insurance support. Ro is cheapest over time if your insurance covers the medication, because that $25/month copay saves $400+ a month versus cash pricing. The math swings on whether you have insurance and whether they’ll cover it. That’s why running the free coverage checker first is the right first move.

Ro’s free Coverage Checker — takes about a minute, no commitment.

The honest tradeoff with Ro (and when to skip it)

Here’s the part most affiliate pages skip. We’re going to tell you up front.

Ro Body charges $149/month on top of your medication. That’s higher than Sesame, Hims & Hers, GoodRx Care, and the no-subscription path at Walgreens. If you already have a valid Wegovy or Zepbound prescription from your PCP — and you’re paying cash with no insurance to fight — Ro’s membership is paying for clinical work you don’t need. In that situation, NovoCare Pharmacy (for Wegovy), LillyDirect (for Zepbound), or Amazon Pharmacy will sell you the medication directly with no telehealth fee at all. Walgreens Weight Management at $49/visit is the next-cheapest path if you still want a clinician check-in.

But the membership pays for itself in one situation: commercial insurance. Wegovy lists at $1,349/month. Zepbound lists at around $1,086/month. With insurance coverage and an approved prior authorization, both drop to as little as $25/month. The reason most people never get there isn’t that their plan doesn’t cover it — it’s that the prior authorization paperwork is a wall. Ro’s insurance concierge does that paperwork for you. If they get you covered, the savings on the first month of medication alone covers more than the full year of membership.

So:

• Already have a valid Rx + paying cash? Skip Ro. Go to NovoCare, LillyDirect, or Amazon Pharmacy direct.
• Commercial insurance and unsure of coverage? Ro’s Coverage Checker is the fastest route.
• Self-pay, no Rx, hate subscriptions? Walgreens at $49/visit.

Knowing when not to recommend something is how you trust a recommendation when we make one.

If you have insurance: who actually handles prior authorization

Wegovy lists at $1,349/month and Zepbound at around $1,086/month. With commercial insurance coverage and an approved prior authorization, both drop to as little as $25/month. Of the verified dual-brand providers, the strongest insurance/PA support comes from Ro Body (free Coverage Checker + dedicated concierge), WeightWatchers Clinic (insurance coordinator, commercial plans only), and Sesame Care (provider-handled, varies by clinician). Walgreens Weight Management is currently self-pay only.

Prior authorization is the part of insurance most people don’t see coming. Your doctor writes a prescription. The pharmacy tries to fill it. Your insurer says “wait, we need to confirm this is medically necessary before we’ll cover it.” Your doctor’s office then has to send paperwork — usually a form documenting your BMI, weight-related conditions, prior weight-loss attempts, and the reason for choosing this medication. The insurer reviews it. They approve, deny, or ask for more. The whole cycle takes anywhere from 48 hours to three weeks.

If your provider’s office is overwhelmed, the paperwork sits on a desk. Most denials in this space aren’t because the patient wasn’t eligible; they’re because the request was incomplete or never submitted in the first place.

How each provider helps with PA

Ro’s Coverage Checker — what it actually does

You enter your insurance details. Ro’s system contacts your insurer (or pulls from an integrated database). Within a minute or two, you get a free report showing whether Wegovy and Zepbound are on your plan’s formulary, your estimated copay, and whether your plan requires prior authorization. No charge. No membership commitment to view the report. If you decide to sign up after seeing it, Ro’s insurance concierge files the PA on your behalf.

Run Ro’s free GLP-1 Insurance Coverage Checker — see your real copay before paying anything.

What if my insurance denies the prior authorization?

Denials are common. Most are appealable. The most successful appeals include documentation of weight-related conditions (high blood pressure, sleep apnea, prediabetes, fatty liver disease, etc.), prior weight-loss attempts, and a letter of medical necessity from your prescribing clinician. Ro’s concierge and WW’s insurance coordinator both submit appeals. Sesame leaves that to the clinician you chose. If you’ve been denied at one provider, you can transfer your prescription to another telehealth platform — your prescription belongs to you, not the platform — though most readers find it easier to start the appeal where they began.

What about Medicare, Medicaid, and VA?

Medicare Part D currently does not cover GLP-1 medications when prescribed solely for weight loss. There are two existing exceptions:

• Wegovy may be covered when prescribed for cardiovascular risk reduction in adults with established heart disease and obesity or overweight.
• Zepbound may be covered when prescribed for moderate-to-severe obstructive sleep apnea in adults with obesity (FDA-approved indication).

Beginning July 1, 2026, the new Medicare GLP-1 Bridge program will cover eligible GLP-1 medications at a $50/month copay for qualifying Part D beneficiaries. Eligible drugs include all formulations of Foundayo, all formulations of Wegovy (injection and tablets), and the KwikPen formulation of Zepbound only. Single-dose vials and single-dose pens of Zepbound are not included. CMS extended the program through December 31, 2027 following the announcement that the BALANCE Model would not launch as originally planned in 2027.

Eligibility is based on BMI of 35+ alone, or 27+ with certain weight-related conditions. Beneficiaries who qualify for coverage under the existing Part D benefit (for example, Wegovy for cardiovascular risk reduction or Zepbound for sleep apnea) won’t qualify under the Bridge — Part D covers them through the regular formulary process instead.

If you’re on Medicare and don’t qualify for an existing indication, the most realistic path right now is:

1. Check whether your situation maps to the cardiovascular or sleep apnea indication. If yes, work with your PCP or telehealth provider to get covered through Part D.
2. If no, prepare for the Medicare GLP-1 Bridge. Mark July 1, 2026 on your calendar. CMS will release more guidance through Spring 2026 on the prior authorization process.
3. Or pay cash through LillyDirect, NovoCare, or Amazon Pharmacy in the meantime. Medicare patients can pay cash; they just can’t use the manufacturer savings programs.

If you’re paying cash: the lowest-friction self-pay path

If you don’t have insurance — or your plan explicitly excludes weight-loss medications — your three best self-pay paths in 2026 are Walgreens Weight Management ($49/visit, no subscription, manufacturer-matched medication prices), the manufacturer programs themselves (NovoCare Pharmacy for Wegovy, LillyDirect for Zepbound — no telehealth fee but you need an existing prescription), and Amazon Pharmacy via One Medical for fast fulfillment. Ro Body remains a strong option if you want bundled clinical support and don’t mind the membership.

Cash-pay shouldn’t mean “the most expensive option.” With NovoCare and LillyDirect both running aggressive self-pay programs in 2026, you can get the same medication at the same price as somebody using insurance with a $25 copay — it just costs $149–$449/month depending on the medication and dose.

The cash-pay decision matrix

Decision Resolution Point: If you’re paying cash and want the simplest, cheapest legitimate path with a real clinician evaluation, Walgreens Weight Management is it. $49 per visit, no recurring charges, manufacturer-matched medication pricing, pickup at any Walgreens or any pharmacy you choose. Eligible adults ages 18–64.

Check Walgreens Weight Management visit availability →

Wegovy or Zepbound: which one will the doctor pick for you?

Wegovy and Zepbound are both FDA-approved for chronic weight management. In manufacturer trials, the highest doses produced average weight loss of about 15% with Wegovy (semaglutide 2.4 mg over 68 weeks) and about 20% with Zepbound (tirzepatide 15 mg over 72 weeks) in non-diabetic adults paired with diet and exercise. The clinician’s choice usually comes down to three things: which medication your insurance covers, whether you want a pill (only Wegovy offers one), and your tolerance for side effects.

You don’t need to decide between Wegovy and Zepbound before booking — and that’s actually the point of choosing a route that carries both. Your clinician picks. But it helps to know what’s on the menu.

Wegovy in plain English

• Active ingredient: semaglutide (a GLP-1 receptor agonist)
• How it’s taken: weekly injection (0.25 → 2.4 mg, plus a higher-dose Wegovy HD at 7.2 mg) or a once-daily pill (1.5, 4, 9, or 25 mg)
• Average weight loss in trials: about 15% on the highest-dose injection over 68 weeks. About 1 in 4 adults on the 25 mg pill lost ≥20% of body weight in a 64-week trial.
• Other FDA-approved uses: lowering risk of major cardiovascular events in adults with established heart disease and obesity or overweight; treating moderate-to-severe metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis.
• Made by: Novo Nordisk

Zepbound in plain English

• Active ingredient: tirzepatide (a dual GLP-1 + GIP receptor agonist)
• How it’s taken: weekly injection only — single-dose pen, single-dose vial, or multi-dose KwikPen
• Average weight loss in trials: about 20% on the highest dose (15 mg) over 72 weeks
• Other FDA-approved uses: treating moderate-to-severe obstructive sleep apnea in adults with obesity
• Made by: Eli Lilly

Doctor-choice checklist — what your clinician actually weighs

1. Which medication does your insurance cover (if any)? That’s usually the deciding factor.
2. Pill or injection? Only Wegovy comes as a pill. Some people strongly prefer one or the other.
3. What’s your medical history? Both medications carry the same FDA boxed warning (do not use if you or a family member have a history of medullary thyroid carcinoma or MEN 2). Past gallbladder, kidney, or pancreatic issues may also shift the choice.
4. What are you targeting? Higher peak weight loss = Zepbound. Cardiovascular risk reduction = Wegovy. Sleep apnea = Zepbound. MASH with liver fibrosis = Wegovy.
5. Prior GLP-1 history? If you’ve tried one and didn’t tolerate it well, the doctor often switches you to the other class.
6. What’s the lowest current self-pay price? As of May 2, 2026, Wegovy pill at $149/month is the lowest-cost branded entry point for cash-pay patients.

If you’re undecided and uninsured, most clinicians start patients on whichever medication has the lowest current self-pay program — typically Wegovy pill — and adjust if you don’t tolerate it.

Decision Resolution Point: If you want the doctor to pick between Wegovy and Zepbound based on your specific situation — instead of being locked into one because that’s all your provider stocks — Ro, Sesame, Hims & Hers, and WeightWatchers Clinic all carry both. Ro is the only one of those that runs your insurance through a free Coverage Checker before you commit.

Check what your insurance covers on Ro (free, no commitment)

Is online Wegovy and Zepbound real? (How to spot a fake provider)

Yes, you can get genuine FDA-approved Wegovy and Zepbound through legitimate U.S. telehealth providers. The medication ships in original Novo Nordisk or Eli Lilly packaging from licensed U.S. pharmacies. The red flags are platforms that skip the medical evaluation, ship without a valid prescription, or sell unapproved compounded versions of semaglutide or tirzepatide as if they were the same as the brand-name drug. None of the verified providers on this page do that.

Here’s the part that gets confusing fast. There’s a separate category of medication called “compounded semaglutide” or “compounded tirzepatide.” A compounded GLP-1 drug is prepared by a compounding pharmacy. It is not FDA-approved, has not been reviewed by the FDA for safety, effectiveness, or quality, and is not a generic version of Wegovy or Zepbound. The FDA has been clear that companies cannot market compounded versions as the same as, generic equivalents of, or clinically proven like FDA-approved Wegovy or Zepbound.

Compounded medications may be lawful only when specific compounding rules are met. They are not the same as brand-name Wegovy or Zepbound, and you shouldn’t pay brand-name prices for a compounded product or assume a compounded prescription will deliver Wegovy or Zepbound results.

This page only ranks providers for brand-name Wegovy and Zepbound. If you’re considering compounded options separately, that’s a different conversation.

The FDA’s red flags for online pharmacies

A safe online pharmacy or telehealth provider:

• Always requires a valid prescription before dispensing
• Has a U.S. physical address and a phone number you can call
• Has a licensed pharmacist available to answer questions
• Is licensed by a state board of pharmacy
• Ships brand-name medication in original Novo Nordisk or Eli Lilly packaging
• Discloses subscription terms, cancellation policy, and total cost upfront

Red flags (avoid):

• Sells Wegovy or Zepbound without a prescription (this is illegal)
• Promises guaranteed approval before reviewing your medical history
• Markets compounded semaglutide or tirzepatide as equivalent to Wegovy or Zepbound
• Has no contact phone number, only a chatbot
• Pricing or terms change between landing page and checkout

Every provider in our verified matrix meets the FDA’s published markers for legitimate online pharmacies and prescribers.

Important safety information

Wegovy and Zepbound are not for everyone. Both carry an FDA boxed warning: do not use if you or a family member have a personal history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Both also list serious hypersensitivity to ingredients as a contraindication. A history of pancreatitis is not a formal contraindication, but it is a safety issue your clinician will want to weigh carefully before prescribing. Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, and fatigue. Serious side effects can include thyroid C-cell tumors, pancreatitis, gallbladder problems, low blood sugar (especially in patients also taking insulin or sulfonylureas), kidney problems, vision changes, and increased risk of depression or suicidal thoughts. Discuss your full medical history with your provider before starting. See the official prescribing information for Wegovy and Zepbound for the complete safety profile.

Already have a prescription? You might not need a provider at all

If you already have a valid Wegovy or Zepbound prescription, you don’t need to pay a telehealth membership. NovoCare Pharmacy (for Wegovy), LillyDirect (for Zepbound), Amazon Pharmacy, and your local pharmacy can fill it directly — at the same self-pay prices the major telehealth providers match ($149–$399/month for Wegovy; $299–$449/month for Zepbound).

Here’s the thing the affiliate marketing world doesn’t really want you to know: you can skip the telehealth subscription entirely if you already have a prescription. The manufacturers and pharmacies will sell you the drug directly.

Your route if you already have an Rx

NovoCare, LillyDirect, and Amazon Pharmacy aren’t telehealth platforms. They don’t have clinicians on staff, they don’t write prescriptions, and they don’t help with insurance. They’re pharmacy fulfillment. That makes them the cheapest path if you have the prescription part already handled.

Provider deep dives: who fits which kind of person

Ro Body — best overall for Wegovy and Zepbound

Punchline: The strongest single fit for most people with commercial insurance. Ro is the only provider on this list with a free, public Insurance Coverage Checker that doesn’t require a membership to view, an insurance concierge that actually files prior authorization paperwork, and one of the broadest publicly listed brand-name GLP-1 formularies across both medications.

What Ro stocks: Wegovy pen (0.25 / 0.5 / 1 / 1.7 / 2.4 mg) | Wegovy pill (1.5 / 4 / 9 / 25 mg) | Zepbound single-dose pen (insurance billing path) | Zepbound KwikPen (cash-pay path) | Foundayo (orforglipron, FDA-approved 4/1/2026) | Ozempic | Mounjaro

What it costs:

• Membership: $39 first month, then $149/month — or as low as $74/month with annual prepay
• Wegovy pen: $199/month intro (first 2 fills), then $349/month (NovoCare-matched)
• Wegovy pill: $149/month intro (1.5 / 4 mg through 8/31/2026), then $299/month
• Zepbound KwikPen: up to $449/month (LillyDirect-matched)
• With commercial insurance coverage: as low as $25/month for the medication

Insurance support: Free GLP-1 Insurance Coverage Checker (no sign-up required to see results); insurance concierge files PA paperwork; ~2–3 week approval cycle when prior authorization is required.

Speed to first dose: Cash pay — typically less than a week per Ro’s published process. With insurance — typically 2–3 weeks during PA.

Who Ro fits best:

• You have commercial insurance and want someone else to fight for coverage
• You want both medications under one provider so the doctor can choose
• You’re okay with a monthly membership in exchange for end-to-end service
• You want one team handling prescriptions, side effects, dose adjustments, and refills

Who Ro doesn’t fit:

• You hate any subscription → try Walgreens or Hims & Hers
• You already have a valid prescription and just need it filled → NovoCare, LillyDirect, or Amazon Pharmacy
• You’re on Medicare, Medicaid, or VA → Ro can’t currently coordinate coverage for government plans (small FEHB exception)

Sesame Care — best if you want to choose your own clinician

Punchline: A telehealth marketplace where you browse and pick your own clinician based on reviews, schedule a video visit (often same-day), and access roughly 14 weight-loss medication options including both Wegovy and Zepbound. Best fit if you’ve had bad experiences with random-assignment telehealth and want a real human you chose.

What Sesame stocks: Wegovy pen, Wegovy pill, Zepbound vial, Zepbound KwikPen, Zepbound single-dose pen, Foundayo, Ozempic, Mounjaro, Saxenda, Rybelsus, plus non-GLP-1 alternatives.

What it costs: Success by Sesame program: $99/month, or $59/month with an annual subscription. Billed every 28 days, not calendar-monthly. Medication is separate. Zepbound vial pricing follows LillyDirect tiers ($299/$399/$449 by dose); Sesame’s KwikPen and single-dose pen pricing runs higher at upper doses.

Insurance support: Provider-handled. The clinician you pick handles PA paperwork. Quality varies. Read provider reviews and pick a clinician who explicitly mentions GLP-1 PA experience.

Speed to first dose: Same-day video visits are common. Prescriptions can transmit to your local pharmacy during the call.

Who Sesame fits best:

• You want to pick your own clinician
• You’re a Costco member (Costco partnership unlocks an extra Wegovy member discount)
• Same-day visits matter
• You want a less-corporate-feeling experience

Who Sesame doesn’t fit:

• You want a single concierge team handling everything → Ro
• The 28-day billing cycle bothers you — it shifts your billing date forward each year

Browse Sesame providers and book a same-day visit

Walgreens Weight Management — best if you hate subscriptions

Punchline: Pay $49 for a video visit, $49 for any follow-up, that’s it. No monthly membership. Pick up your prescription at any Walgreens — or any pharmacy you choose. Lowest-commitment path on this list.

What Walgreens stocks: Wegovy pen, Wegovy pill, Zepbound vials, Zepbound KwikPen, Foundayo, Saxenda.

What it costs: $49 per visit + manufacturer-matched medication ($149/$199 Wegovy intro pricing; $299–$449 Zepbound).

Insurance support: None currently. Walgreens has stated it may add insurance support in the future, but the program is positioned for self-pay patients today. Eligible adults ages 18–64 who are overweight or obese.

Who Walgreens fits best:

• Paying cash and don’t need PA support
• Want to pick up locally instead of waiting for shipping
• Hate any subscription
• Just want a clinician check, a prescription, and a refill — no add-ons

Who Walgreens doesn’t fit:

• Commercial insurance and you need someone to fight for coverage → Ro
• Outside the 18–64 age range → Ro or your PCP

Check Walgreens Weight Management visit availability →

Hims & Hers — best familiar consumer telehealth brand

Punchline: Following the March 2026 Novo Nordisk collaboration and the April 23, 2026 LillyDirect routing announcement, Hims & Hers now supports both ends of the FDA-approved GLP-1 menu. Wegovy injections and pills come through the Novo collaboration; Zepbound vials, KwikPen, and Foundayo are routed through LillyDirect for self-pay pricing.

What Hims & Hers stocks: Wegovy pen (all doses), Wegovy pill, Zepbound vial, Zepbound KwikPen, Foundayo, Ozempic.

What it costs: Membership required. Wegovy starts around $149/month at intro pricing. Zepbound and Foundayo match LillyDirect self-pay pricing.

Insurance support: Membership-based clinical care; the platform doesn’t currently advertise a Coverage Checker comparable to Ro’s. Best fit for self-pay readers or those who want a familiar consumer brand.

Who Hims & Hers fits best:

• You want a familiar male-coded (Hims) or female-coded (Hers) consumer telehealth brand
• You’re paying cash and want both brand-name medication menus on one platform
• You want bundled care (24/7 messaging, nutrition, peer community)

Who Hims & Hers doesn’t fit:

• Insurance is your biggest unknown → Ro
• You don’t want a recurring membership → Walgreens

Get started with Hims & Hers weight loss

WeightWatchers Clinic (WW Med+) — best for clinical care + behavior support

Punchline: WW Med+ pairs FDA-approved GLP-1 prescribing with the WeightWatchers behavioral program and a dedicated insurance coordinator that handles commercial-plan prior authorization. WW says WW Clinic patients on a GLP-1 lost an average of 21% of body weight at 12 months in WW’s internal study of 3,250 members — that’s WW’s internal data, not a guarantee of individual results.

What WW stocks: Wegovy (pen and pill), Zepbound, Saxenda, Metformin, Naltrexone-Bupropion (Contrave).

What it costs: Membership required (medication separate). Self-pay 12-month medication commitment for Wegovy: $249/month per fill, prepaid upfront at $2,988 total for qualifying doses (pill or injectable).

Insurance support: Insurance coordinators handle PAs and refills — commercial only. Government plans (Medicare, Medicaid, VA), Kaiser, and uninsured patients are not supported.

Who WW fits best:

• You want the behavioral program and the prescription bundled
• You have commercial insurance
• You like accountability, weekly check-ins, and a community

Who WW doesn’t fit:

• Government insurance, Kaiser, or no insurance and you want flexibility → Ro or Walgreens
• You don’t want behavioral coaching, just the prescription → Ro or Walgreens

Eden, Found, Noom Med, GoodRx Care, and Amazon — short profiles

Eden carries brand-name Wegovy and Zepbound alongside compounded options. Its differentiator is the “Same Price at Every Dose” guarantee on its compounded program. For brand-name Wegovy or Zepbound specifically, Eden is significantly more expensive than direct manufacturer routes — Eden lists Wegovy at $1,695/month and Zepbound at $1,399/month versus $149–$449 through NovoCare/LillyDirect-matched providers. Choose Eden’s brand-name option only if you specifically want their care model and want to use HSA/FSA dollars at checkout. See Eden’s GLP-1 options

Found has insurance partnerships with select carriers in some states, plus active promo discounts on select plans. Carries Wegovy pen, Wegovy pill, and Zepbound vials. Worth comparing if you live in a state where Found is in-network with your insurance.

Noom Med layers behavioral coaching on top of GLP-1 prescribing. Currently advertises a $69 first-30-days branded-medication trial. Carries both Wegovy and Zepbound; medication is separate from the program fee and filled through a pharmacy partner. Best if you specifically want the Noom psychology program.

GoodRx Care is a verified telehealth path for both medications with a $39/month membership listed publicly. See GoodRx Care GLP-1 options

Amazon Pharmacy via One Medical carries Wegovy oral, Wegovy injectable, Zepbound single-dose pen, and Zepbound KwikPen, with cash-pay starting at $149/month for orals and $299/month for injectables. One Medical visits are accepted by most major insurance plans. Best if you already have a prescription, or if fast pharmacy fulfillment matters more than ongoing clinical handholding.

Ro vs. Sesame vs. Walgreens vs. Hims & Hers — the head-to-head

Choose Ro if commercial insurance coverage is your biggest unknown. Choose Sesame if you want to pick your own clinician. Choose Walgreens if you’re paying cash and refuse to pay any subscription. Choose Hims & Hers if you want a familiar consumer brand with both brand-name medication menus on one platform. All four carry brand-name Wegovy and Zepbound.

Ro vs. Sesame

Ro vs. Walgreens

Hims & Hers vs. Ro

Decision Resolution Point: If you’re stuck between Ro and Walgreens, ask yourself one question: do you want the clinician to fight your insurance for you? If yes, Ro. If no — and you’re fine paying cash at the manufacturer-matched price — Walgreens is roughly $100/month cheaper.

How fast can you actually start?

Self-pay patients typically receive their first dose within a week through Ro or Walgreens, per each provider’s published process. Insurance-coverage patients usually wait 2–3 weeks while prior authorization processes. Sesame Care can complete a same-day video visit and transmit a prescription to your local pharmacy during the call itself.

What can delay your first dose:

1. Prior authorization required — adds 2–3 weeks for most plans
2. Pharmacy stock — high-demand doses occasionally backorder
3. Dose or format availability — Wegovy HD, Zepbound KwikPen rollouts vary by region
4. Lab work required — some providers (notably Sesame) may order baseline labs before prescribing
5. State clinician availability — some smaller telehealth platforms aren’t licensed in every state
6. Prescription transfer from another provider — usually adds a day or two

Required intake (typical for all)

Whatever provider you choose, expect questions about:

• Height, current weight, BMI
• Medical history (heart disease, diabetes, kidney issues, GI history, gallbladder, pancreatitis, thyroid cancer family history)
• Current medications and supplements
• Past weight-loss efforts and results
• Any GLP-1 history
• Pregnancy or planning to become pregnant
• Mental health history
• Insurance and pharmacy preferences

If a platform asks fewer questions than these and just hands you a prescription, that’s the FDA red flag — leave.

What we actually verified

Every provider, price, and format on this page was checked against the source on May 2, 2026. Here’s the receipt.

Items we re-verify monthly because they expire on dated cycles: Wegovy intro pricing windows (6/30/2026 and 8/31/2026), Zepbound 45-day refill rule and tier pricing, Ro membership pricing, Sesame program pricing, Hims & Hers state-by-state availability.

Frequently asked questions

Final routing — pick your path

You came here to find GLP-1 providers that prescribe Wegovy and Zepbound. Now you have the verified routes, the pricing matrix, the insurance map, and the segmentation to pick yours.

For most people, the highest-leverage first move is Ro Body’s free GLP-1 Insurance Coverage Checker. It costs nothing, takes about a minute, and tells you the single most important fact for this decision: whether your insurance turns a $1,349 list-price medication into a $25 copay. If yes, Ro’s concierge gets you there. If no, you’ve spent a minute and you can pivot to Walgreens at $49/visit, Sesame at $99/month, Hims & Hers, or one of the manufacturer programs directly. Either way, you’ve made the decision with real information instead of marketing copy.

Free; no membership required to view your report.

Or check Walgreens Weight Management visit availability → (if you’re paying cash and want no subscription)

Sources and citations

• Ro Body — pricing, formulary, Insurance Coverage Checker: ro.co/weight-loss/wegovy/, ro.co/weight-loss/zepbound/, ro.co/weight-loss/pricing/, ro.co/weight-loss/glp1-insurance-checker/
• Sesame Care — Success by Sesame program: sesamecare.com/service/online-weight-loss-program, sesamecare.com/medication/zepbound, sesamecare.com/medication/wegovy
• Walgreens Weight Management — Wegovy and Zepbound pages: walgreens.com/topic/virtual-healthcare/weight-loss/
• WeightWatchers Clinic / WW Med+: weightwatchers.com/us/weight-loss-medication
• Hims & Hers — April 23, 2026 LillyDirect routing announcement: news.hims.com (April 23, 2026); investors.hims.com
• Eden — provider directory: tryeden.com
• Amazon Pharmacy / One Medical GLP-1 program: aboutamazon.com
• GoodRx Care: goodrx.com/care/services/glp-1-weight-loss
• NovoCare Pharmacy — Wegovy self-pay program: novocare.com/pharmacy.html
• LillyDirect — Zepbound Self-Pay Journey Program: zepbound.lilly.com/savings, lilly.com/lillydirect
• Medicare GLP-1 Bridge program (July 1, 2026 – December 31, 2027): cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
• FDA — Wegovy and Zepbound prescribing information; FDA guidance on compounded GLP-1 marketing claims (fda.gov)

This page is for informational purposes and is not medical advice. Wegovy and Zepbound are prescription medications that require evaluation by a licensed clinician. Discuss your full medical history with your provider before starting any GLP-1 medication. We are an independent comparison resource for GLP-1 telehealth providers and may earn a commission when readers sign up through some of the providers linked above. Commissions do not change which providers appear in our verified matrix — only verified evidence and reader fit do.

Last verified: May 2, 2026. Next scheduled re-verification: June 1, 2026.